Larry Schlesinger, MD
President and CEO
Texas Biomedical Research Institute
Dr. Schlesinger is leading a transformational change process to develop Texas Biomed into a world-renowned infectious disease research institution that is twice its current size with a focus on diseases impacting our lives today and in the future. His aim is to revolutionize the way scientists perform science, focusing on greater collaboration and a holistic approach to studying disease from basic biology to the development of diagnostics, therapies, and vaccines. He will share thoughts on how Texas can capitalize on its pioneering and collaborative spirit to become an even greater force in biomedicine on the global stage in the coming years.